文献速递介入腹部外周血管DSACTMR

存在腹水患者原发性肝肿瘤的放射性栓塞治疗:超越Child-Pugh评分

Radioembolization of primary liver tumors for patients with pre-existing ascites: beyond Child-Pugh score.
PubMed 文献 · Abdom Radiol (NY) · 2025-12-11

回顾性分析288次TARE(237例原发性肝肿瘤),评估基线腹水与治疗后腹水加重的关联及生存。既存腹水与TARE后腹水进展无关,但ALBI分级较高(OR=2.87)和基线肝硬化(OR=2.64)与TARE后腹水相关。既存腹水与生存较差相关(HR=2),但不应排除TARE。

要点

  • 既存腹水与TARE后腹水进展无独立关联,但ALBI分级较高和基线肝硬化是危险因素。
  • 既存腹水(HR=2)和TARE后新发/加重腹水(HR=2.1)均与生存较差相关。
  • ALBI评分有助于区分TARE后腹水高风险患者,既存腹水不应排除TARE。

核心结论

  • 既存腹水与生存较差相关但不应排除TARE;ALBI评分有助于识别TARE后腹水高风险患者。

研究设计与样本

  • 回顾性分析288次TARE(237例原发性肝肿瘤),评估TARE前及TARE后6个月影像学腹水情况,采用逻辑回归分析肝失代偿危险因素,绘制总体生存曲线。

诊断标准与关键数值

  • 既存腹水与TARE后腹水进展无显著关联。
  • ALBI分级较高与TARE后腹水相关(OR=2.87,p<0.001)。
  • 基线肝硬化与TARE后腹水相关(OR=2.64,p=0.007)。
  • Child-Pugh分级与生存较差相关(HR=2.3,p<0.001)。
  • 既存腹水与生存较差相关(HR=2,p<0.001);ALBI评分(HR=1.5,p<0.011);新发/加重腹水(HR=2.1,p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: This study evaluates baseline characteristics associated with worsening ascites following TARE focusing on evaluation of the pre-existing ascites as a risk factor. A secondary objective was to examine survival among patients who developed ascites after TARE.

METHODS: A total of 288 TARE deliveries (237 patients) for primary liver tumors were retrospectively reviewed. Imaging before and six months after TARE was assessed for ascites. Tumor volume, treated area, delivered activity, and liver function tests and underlying etiology of liver disease were reviewed. Logistic regression was performed for risk factors of liver decompensation including pre-existing ascites as a risk factor. Survival curves were plotted for overall survival.

RESULTS: Mean (SD) age was 66 (11). 204 were male (71%). Median follow-up was 12.3 months (IQR 5.5-23.5). Of 288 tumors, 266 (92%) were HCC, 11 (4%) IHC, and 11 (4%) biphenotypic. 60 (of 288, 21%) patients had pre-existing ascites. New/worsening ascites occurred in 121 (of 288, 42%) [93 (77%) new, 28 (23%) worsening]. Patients with new/worsening ascites had significantly greater increases in bilirubin (p = 0.01, p < 0.001). In multivariable regression analysis pre-existing ascites was not associated with increased risk of post-TARE ascites progression, but a higher ALBI grade (OR = 2.87, p < 0.001) and baseline liver cirrhosis (OR = 2.64, p = 0.007) were associated with ascites after TARE. Neither perfused volume nor activity delivered predicted new/worsening ascites. Child-Pugh class (HR = 2.3, p < 0.001), pre-existing ascites (HR = 2, p < 0.001), ALBI score (HR = 1.5, p < 0.011) and new/worsening ascites (HR = 2.1, p < 0.001) were associated with lower survival.

CONCLUSIONS: Pre-existing ascites is associated with worse survival but should not preclude TARE. ALBI scoring can help distinguish patients at higher risk of post-TARE ascites.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Jabboure FJ, Marlow JA, Reed WD, et al. Radioembolization of primary liver tumors for patients with pre-existing ascites: beyond Child-Pugh score. Abdom Radiol (NY). 2025. PMID: 41379141. doi:10.1007/s00261-025-05336-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。